I think the Australians have outsmarted themselves by drinking the fool's kool-aid of capitalistic excess and oversupply ... with the internal cracks and tensions already surfacing and plain for everyone to see. I think this will serve to strengthen Vale's position as it quietly works to maximize cost efficiencies and deliver the highest grade iron ore in the world.
pathetic, these boys down under. Vale will be the lowest cost producer of the lot
The execs at Delcath have to start buying some of their own stock down here at these historic low levels, don't they ... Just as they've been trying to impress others to do at these Needham-like conferences.
They really need to step it up by signing up enrollees as well for the phase 3 ocular - it can be done quicker, no doubt. It will take some work, but that's why they're getting paid the big bucks, and it's been two whole years already since the last trial and ODAC decision, which is already more than enough time to get their ducks in a row
Like I said, dumping excess ore into a saturated market -- with inefficient, unprofitable Chinese miners not closing because of government subsidies -- is a hair brain idea that has already cost shareholders billions of dollars ... and anyone can try to pick a number out of a hat for where prices will eventually converge -- lower or higher from here. But what looks more clear to me is that they are the short's best friend.
Macquarie initiates coverage at Outperform
Well, takes two sides to make a market. personally I think the other side has gotten too crowded, and added to my holdings down here
... sure seems that way in this upside year
Problem is, unless CI and friends can overtake them, this management team would have to be convinced to give up their cozy little stock option printing machine ... which they probably feel is the best thing they've stumbled upon since sliced bread
sam - none of this sadly merits debating anymore. There is a shareholder lawsuit, which I presume is going forward at this point, and there is a 'theoretical culprit', to use your nicely-coined phrase, who left behind what was a promising company that has lost, again, about what -- another 80% of its value since doing the dubious stock split (surprise surprise). It did not have to be this way, and I would add certainly should not have been.
Why not? One can hope for success for Dcth's novel treatment and its benefit for cancer patients while not absolving prior management for certain actions and decisions that have put the company -- and shareholders -- in the dire situation of today.
melikes, I stay out of the crossfire between you and Akon, but I would say that the lawsuit for what its worth is not frivolous ... the actions taken by then management are highly dubious and worked to really scr*w over shareholders and the company, bringing us to where we are now -- under 7 cents original pre-split price.
still about $2.11 in cash per share, with some interesting junctures (or crossroads) coming up.
Either way you look at it, management should have by now some skin in the game and be buying some of their own company's shares -- just like many have here -- and especially at these low fire sale prices, 7 cents or not.
Agree with you melikes, about the fingers ... but while many here have given many or all of them, I can't help but wonder what's keeping this management team and directors from putting any of their own skin in the game ...
Yes, but do you mean for Stoller, Simpson & Co.? ... to buy some of their own shares and to have some skin in the game like the rest of us ... rather than just taking equity out?